Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1) an-label, 2 trial

de Bono, JS; Mehra, N; Scagliotti, GV; Castro, E; Dorff, T; Stirling, A; Stenzl, A; Fleming, MT; Higano, CS; Saad, F; Buttigliero, C; van Oort, IM; Laird, AD; Mata, M; Chen, HC; Healy, CG; Czibere, A; Fizazi, K – 2021